HomeDRMA • NASDAQ
add
Dermata Therapeutics Inc
Previous close
$5.45
Day range
$5.29 - $5.70
Year range
$5.04 - $24.90
Market cap
3.68M USD
Avg Volume
29.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.77M | -38.53% |
Net income | -1.70M | 39.87% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 6.48M | 31.00% |
Total assets | 6.64M | 26.81% |
Total liabilities | 1.03M | -46.50% |
Total equity | 5.61M | — |
Shares outstanding | 681.56K | — |
Price to book | 0.62 | — |
Return on assets | -53.25% | — |
Return on capital | -68.63% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -1.70M | 39.87% |
Cash from operations | -2.69M | -26.55% |
Cash from investing | — | — |
Cash from financing | -547.86K | -123.42% |
Net change in cash | -3.24M | -1,617.36% |
Free cash flow | -2.62M | -142.72% |
About
Founded
2014
Website
Employees
8